John J Cuaron1, Chang Chang2, Michael Lovelock3, Daniel S Higginson3, Dennis Mah4, Oren Cahlon3, Simon Powell3. 1. Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: cuaronj@mskcc.org. 2. Texas Center for Proton Therapy, Irving, Texas. 3. Memorial Sloan Kettering Cancer Center, New York, New York. 4. Procure Proton Therapy Center, Somerset, New Jersey.
Abstract
PURPOSE: To quantify the relative biological effectiveness (RBE) of the distal edge of the proton Bragg peak, using an in vitro assay of DNA double-strand breaks (DSBs). METHODS AND MATERIALS: U2OS cells were irradiated within the plateau of a spread-out Bragg peak and at each millimeter position along the distal edge using a custom slide holder, allowing for simultaneous measurement of physical dose. A reference radiation signal was generated using photons. The DNA DSBs at 3 hours (to assess for early damage) and at 24 hours (to assess for residual damage and repair) after irradiation were measured using the γH2AX assay and quantified via flow cytometry. Results were confirmed with clonogenic survival assays. A detailed map of the RBE as a function of depth along the Bragg peak was generated using γH2AX measurements as a biological endpoint. RESULTS: At 3 hours after irradiation, DNA DSBs were higher with protons at every point along the distal edge compared with samples irradiated with photons to similar doses. This effect was even more pronounced after 24 hours, indicating that the impact of DNA repair is less after proton irradiation relative to photons. The RBE demonstrated an exponential increase as a function of depth and was measured to be as high as 4.0 after 3 hours and as high as 6.0 after 24 hours. When the RBE-corrected dose was plotted as a function of depth, the peak effective dose was extended 2-3 mm beyond what would be expected with physical measurement. CONCLUSIONS: We generated a highly comprehensive map of the RBE of the distal edge of the Bragg peak, using a direct assay of DNA DSBs in vitro. Our data show that the RBE of the distal edge increases with depth and is significantly higher than previously reported estimates.
PURPOSE: To quantify the relative biological effectiveness (RBE) of the distal edge of the proton Bragg peak, using an in vitro assay of DNA double-strand breaks (DSBs). METHODS AND MATERIALS: U2OS cells were irradiated within the plateau of a spread-out Bragg peak and at each millimeter position along the distal edge using a custom slide holder, allowing for simultaneous measurement of physical dose. A reference radiation signal was generated using photons. The DNA DSBs at 3 hours (to assess for early damage) and at 24 hours (to assess for residual damage and repair) after irradiation were measured using the γH2AX assay and quantified via flow cytometry. Results were confirmed with clonogenic survival assays. A detailed map of the RBE as a function of depth along the Bragg peak was generated using γH2AX measurements as a biological endpoint. RESULTS: At 3 hours after irradiation, DNA DSBs were higher with protons at every point along the distal edge compared with samples irradiated with photons to similar doses. This effect was even more pronounced after 24 hours, indicating that the impact of DNA repair is less after proton irradiation relative to photons. The RBE demonstrated an exponential increase as a function of depth and was measured to be as high as 4.0 after 3 hours and as high as 6.0 after 24 hours. When the RBE-corrected dose was plotted as a function of depth, the peak effective dose was extended 2-3 mm beyond what would be expected with physical measurement. CONCLUSIONS: We generated a highly comprehensive map of the RBE of the distal edge of the Bragg peak, using a direct assay of DNA DSBs in vitro. Our data show that the RBE of the distal edge increases with depth and is significantly higher than previously reported estimates.
Authors: Richard A Britten; Vahagn Nazaryan; Leslie K Davis; Susan B Klein; Dmitri Nichiporov; Marc S Mendonca; Mark Wolanski; Xiliang Nie; Jerry George; Cynthia Keppel Journal: Radiat Res Date: 2012-11-13 Impact factor: 2.841
Authors: Pankaj Chaudhary; Thomas I Marshall; Francesca M Perozziello; Lorenzo Manti; Frederick J Currell; Fiona Hanton; Stephen J McMahon; Joy N Kavanagh; Giuseppe Antonio Pablo Cirrone; Francesco Romano; Kevin M Prise; Giuseppe Schettino Journal: Int J Radiat Oncol Biol Phys Date: 2014-06-28 Impact factor: 7.038
Authors: Harald Paganetti; Andrzej Niemierko; Marek Ancukiewicz; Leo E Gerweck; Michael Goitein; Jay S Loeffler; Herman D Suit Journal: Int J Radiat Oncol Biol Phys Date: 2002-06-01 Impact factor: 7.038
Authors: Nicole Grosse; Andrea O Fontana; Eugen B Hug; Antony Lomax; Adolf Coray; Marc Augsburger; Harald Paganetti; Alessandro A Sartori; Martin Pruschy Journal: Int J Radiat Oncol Biol Phys Date: 2013-11-13 Impact factor: 7.038
Authors: Yanjing Li; Michael Dykstra; Till D Best; Jennifer Pursley; Nitish Chopra; Florence K Keane; Melin J Khandekar; Gregory C Sharp; Harald Paganetti; Henning Willers; Florian J Fintelmann; Clemens Grassberger Journal: Radiother Oncol Date: 2019-04-20 Impact factor: 6.280
Authors: Ming Fan; Jung Julie Kang; Anna Lee; Dan Fan; Huili Wang; Sarin Kitpanit; Pamela Fox; Kevin Sine; Dennis Mah; Sean M McBride; Chiaojung Jillian Tsai; Nadeem Riaz; Lara A Dunn; Eric J Sherman; Loren Michel; Bhuvanesh Singh; Ian Ganly; Richard J Wong; Jay O Boyle; Marc A Cohen; Nancy Y Lee Journal: Cancer Date: 2020-02-25 Impact factor: 6.860
Authors: Bouthaina Shbib Dabaja; Bradford S Hoppe; John P Plastaras; Wayne Newhauser; Katerina Rosolova; Stella Flampouri; Radhe Mohan; N George Mikhaeel; Youlia Kirova; Lena Specht; Joachim Yahalom Journal: Blood Date: 2018-08-14 Impact factor: 22.113
Authors: Qin Zhou; Michelle E Howard; Xinyi Tu; Qian Zhu; Janet M Denbeigh; Nicholas B Remmes; Michael G Herman; Chris J Beltran; Jian Yuan; Patricia T Greipp; Judy C Boughey; Liewei Wang; Neil Johnson; Matthew P Goetz; Jann N Sarkaria; Zhenkun Lou; Robert W Mutter Journal: Cancer Res Date: 2021-02-17 Impact factor: 12.701